LEUVATE™ Technology
Our proprietary LEUVATE™ amino acid formulation represents a breakthrough in muscle protein synthesis optimization. By combining leucine-enriched whey protein isolate with micellar casein, we’ve created a two-phase aminoacidemia profile that maximizes muscle building and recovery.
Clinical Studies
– DePaul University
– McMaster University
– The University of Arkansas
– The University of Toronto
– Queen’s University
– The University of Guelph
Two-Phase Aminoacidemia
Optimized Leucine Loading
Complete EAA Profile
LEUVATE™ Aminoacidemia Profile
- Oral AdministrationT = 0 minmore
- Gastric ProtectionT = 45-60 minmore
- Intestinal AbsorptionT = 45-60 minmore
- Peak Plasma LevelsT = 2-3 hoursmore
- Sustained ReleaseT = 8-12 hoursmore
Quality and Certifications
Manufactured in FDA-registered facilities with rigorous quality control at every stage of production.
GMP CERTIFIED
Good Manufacturing Practices
NSF CERTIFIED
Third-Party Verified
ISO 9001
Quality Management
USP VERIFIED
United States Pharmacopeia
Clinical Research & University Partnerships
Our formulations are being rigorously tested at leading research institutions to validate efficacy and safety. LEUVATE™ is a proprietary nutritional formula developed by leading protein metabolism PhDs. Its effectiveness is supported by three peer-reviewed human clinical trials, as well as our upcoming clinical trial in collaboration with DePaul University, McMaster University, the University of Arkansas, the University of Toronto, the University of Guelph, and Queen’s University, which will further assess LEUVATE™’s effect on whole-body protein synthesis and immune responses.
Welcome on board
Leading Formulators
LEUVATE™ is trusted by innovators in clinical nutrition and active aging. Whether formulating for sarcopenia, weight management, or performance nutrition, LEUVATE™ brings clinical credibility and effective science to your product line.